Developmental abnormalities of cortical interneurons precede symptoms onset in a mouse model of Rett syndrome
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Rett syndrome (RTT, MIM 312750), a neurodevelopmental disorder predominantly occurring in females, is caused in the majority of cases by sporadic mutations in the gene encoding the transcriptional modulator methyl‐CpG‐binding protein 2 (MECP 2). In mice, impaired Me CP 2 function results in severe motor, cognitive, and emotional defects. The lack of Mecp2 in γ‐aminobutyric acid‐(GABA) releasing forebrain interneurons (INs) recapitulate many RTT features, however, the role of this gene in the development of the cortical inhibitory system is still unknown. Here, we found that Me CP 2 expression varies among the three major classes of cortical INs and its nuclear localization differs between neuronal types. The density of calretinin+ and parvalbumin+ IN s increases in Mecp2 knockout mice (Mecp2−/y) already at early post‐natal developmental stages. In contrast, the density of somatostatin+ IN s is not affected. We also found that the development of multipolar‐calretinin+ IN s is selectively affected by the absence of Mecp2. Additionally, we show that in Mecp2 heterozygous female mice, a model closely mimicking human RTT condition, IN abnormalities are similar to those observed in Mecp2−/y mice. Together, our study indicates that loss of function of Mecp2 strongly interferes with the correct establishment of the neocortical inhibitory system producing effects that are specific to different IN subtypes. image The neurological consequences of the Rett syndrome‐related Mecp2 gene mutation are still debated. We disclosed a novel cell‐specific role of MeCP2 in the organization of neocortical GABAergic interneurons assembly during post‐natal development of the mouse brain. Parvalbumin+ and calretinin+ interneurons being the mostly affected. Our data suggest new avenues for the development of biomarkers and therapeutic interventions for Rett syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275
The Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265
Interneuron dysfunction in psychiatric disorders
Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190 · cited 1×
“This is not surprising, especially in view of the well-known involvement of the GABAergic dysfunction in the etiology of other neuropsychiatric disorders such as schizophrenia and autism which share many clinical aspects with RTT (Ramamoorthi and Lin 2011; Marin 2012; Le Magueresse and Monyer 2013).”
BackgroundDysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
The origin and specification of cortical interneurons
Wonders, C. P., & Anderson, S. A. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1954 · Cited by 980
Dani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R., & Nelson, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506071102 · Cited by 639
The temporal and spatial origins of cortical interneurons predict their physiological subtype
Butt, S. J. B., Fuccillo, M., Nery, S., Noctor, S., Kriegstein, A., Corbin, J. G., & Fishell, G. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.034 · Cited by 587
A role for glia in the progression of Rett’s syndrome
Lioy, D. T., Garg, S. K., Monaghan, C. E., Raber, J., Foust, K. D., Kaspar, B. K., Hirrlinger, P. G., Kirchhoff, F., Bissonnette, J. M., Ballas, N., et al. (2011) · Nature · doi:10.1038/nature10214 · Cited by 496
Kishi, N., & Macklis, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.07.006 · Cited by 445
Cited by
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
The Indispensable Roles of Microglia and Astrocytes during Brain Development
Reemst, K., Noctor, S. C., Lucassen, P. J., & Hol, E. M. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00566 · Cited by 516
Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.47 · Cited by 360
Hashemi, E., Ariza, J., Rogers, H., Noctor, S. C., & Martínez-Cerdeño, V. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw021 · Cited by 322
The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
Braat, S., & Kooy, R. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.042 · Cited by 294
Targeting peripheral somatosensory neurons to improve tactile-related phenotypes in ASD models
Orefice, L. L., Mosko, J. R., Morency, D. T., Wells, M. F., Tasnim, A., Mozeika, S. M., Ye, M., Chirila, A. M., Emanuel, A. J., Rankin, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.024 · Cited by 247
Ventral hippocampal projections to the medial prefrontal cortex regulate social memory
Phillips, M. L., Robinson, H. A., & Pozzo-Miller, L. (2019) · eLife · doi:10.7554/elife.44182 · Cited by 205
“Notably, the amplitude of vHIP-evoked VSD signals in mPFC slices from Mecp2 KO mice did not show the typical developmental reduction between P20-25 and P45-50 observed in WT slices, resulting in significantly larger responses in symptomatic Mecp2 KO mice compared to age-matched WT mice (Figure S5), similar to CA3-evok…”
BackgroundInfluentialPatrizi, A., Picard, N., Simon, A. J., Gunner, G., Centofante, E., Andrews, N. A., & Fagiolini, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.018 · Cited by 100
“In the absence of MECP2, PV circuits exhibit a significant increase in neurite complexity and number of axonal perisomatic boutons onto pyramidal cells starting as early as eye opening (P15), which contributes to the silencing of cortical circuits (14,20,49).”
Loss of MECP2 Leads to Activation of P53 and Neuronal Senescence
Ohashi, M., Korsakova, E., Allen, D., Lee, P., Fu, K., Vargas, B. S., Cinkornpumin, J., Salas, C., Park, J. C., Germanguz, I., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.001 · Cited by 80
“Studies in murine models recapitulate many of the patient phenotypes and have recently identified a role for Mecp2 particularly in inhibitory neurons (Tomassy et al., 2014).”
BackgroundCell-Specific Regulation of N-Methyl-D-Aspartate Receptor Maturation by Mecp2 in Cortical Circuits
Mierau, S. B., Patrizi, A., Hensch, T. K., & Fagiolini, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.018 · Cited by 50
Accelerated Hyper-Maturation of Parvalbumin Circuits in the Absence of MeCP2
Patrizi, A., Awad, P. N., Chattopadhyaya, B., Li, C., Di Cristo, G., & Fagiolini, M. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhz085 · Cited by 46
“2008), and cortices (Durand et al. 2012; Tomassy et al. 2014; Krishnan et al. 2015) but all of them agree that such alterations precede the onset of RTT symptoms.”
BackgroundMethodResultInfluential
Metadata
- Authors
- Tomassy, G. S., Morello, N., Calcagno, E., & Giustetto, M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2014-08-05
- Volume
- 131
- Issue
- 1
- Pages
- 115-127
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1992088096
- Cited by
- 44
- References
- 23
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.